"One Month of Clot Prevention Post-Stent Matches Year-Long AFib Regimen"

A new study presented at the American Heart Associations Scientific Sessions 2025 reveals that a one-month anticoagulant regimen post-stent placement in atrial fibrillation patients is as effective as a year-long treatment in preventing strokes.

• Research presented on Nov. 8, 2025, at the American Heart Associations Scientific Sessions shows a one-month anticoagulant regimen is effective for atrial fibrillation patients post-stent placement.
• The study indicates that the shortened treatment with rivaroxaban and aspirin prevents strokes, heart attacks, and death while reducing the risk of bleeding compared to standard year-long therapies.
• This finding challenges existing practices in managing patients with arrhythmia and suggests that shorter anticoagulant regimens could benefit the circulatory system without compromising safety.